| Brenda Willard, LCP | |
|
6610 Se Quakervale Rd, Riverton, KS 66770-4185 | |
| (620) 848-2300 | |
| (620) 848-2301 |
| Full Name | Brenda Willard |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 6610 Se Quakervale Rd, Riverton, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922131895 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | 305 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Brenda Willard, LCP Po Box 550, Riverton, KS 66770-0550 Ph: (620) 848-2300 | Brenda Willard, LCP 6610 Se Quakervale Rd, Riverton, KS 66770-4185 Ph: (620) 848-2300 |
News Archive
St. Jude Medical, Inc., a global medical device company, today announced CE Mark approval of expanded labelling for its Ellipse implantable cardioverter defibrillator (ICD), in addition to its Durata and Optisure defibrillation leads, allowing existing or future patients with these technologies to undergo magnetic resonance imaging (MRI) scans without compromising device performance.
New research published in the January issue of the Journal of Vascular Surgery® explores the impact that adjustments in statistical reliability can have on hospital quality rankings for vascular surgery. A total of 14,569 patients who underwent common vascular procedures (open and endovascular abdominal aortic aneurysm repair, carotid endarterectomy, lower extremity bypass and aorto-femoral bypass) were identified through the 2007 National Surgical Quality Improvement Project (NSQIP).
An early phase study pairing an experimental targeted therapy with a common anti-inflammatory produced promising results in patients with advanced lung cancer, researchers at UCLA's Jonsson Cancer Center reported.
In the public health field, there is an ongoing debate as to whether improvement in the overall health of the population is linked to increases or decreases in social inequities in health, that is, the inequities between higher-income and lower-income groups or people of different race/ethnicities.
The U.S. Food and Drug Administration today licensed for marketing the first product in the United States intended to protect people with hereditary angioedema (HAE), a rare and potentially life-threatening genetic disease. HAE affects about 6,000 to 10,000 individuals in the United States.
› Verified 2 days ago
Julie Vogel, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 Fax: 620-848-2301 | |
Daniel J Mcnally, MS, TLMLP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 | |
Susan Lopez, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 Fax: 620-848-2301 | |
Clifford Mcquillen Jr., LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 Fax: 620-848-2301 | |
Sally Pullman-rinkel, Psychologist Medicare: Medicare Enrolled Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 Fax: 620-848-2301 | |
Brandi Bruner, Psychologist Medicare: Medicare Enrolled Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 | |
Michael Willis, LCP Psychologist Medicare: Not Enrolled in Medicare Practice Location: 6610 Se Quakervale Rd, Riverton, KS 66770 Phone: 620-848-2300 Fax: 620-848-2301 |